Company

NanoString Technologies, Inc.

NanoString Technologies develops research tools for gene expression and spatial molecular analysis.

About

NanoString Technologies provides life science tools for research, translational medicine and in vitro diagnostics. Its portfolio includes the nCounter analysis system, GeoMx digital spatial profiler and CosMx spatial molecular imager, used in fields such as oncology, immunology and neuroscience. Founded in 2003, the company was based in Seattle, US, and led by CEO Brad Gray. Bruker Corporation acquired it in May 2024 from Patient Square Capital, DFJ, OVP Venture Partners and other investors.

6Funding rounds

6Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in